Experienced Investor
Stock of the week: GlaxoSmithKline
The defensive nature of the sector and the stock, and the competitive yields paid to investors make GlaxoSmithKline a core holding for many portfolios. In recent years, the large companies in the pharmaceutical sector have suffered because of increased levels of generic competition following patent expirations. Although this company is affected, investors should note that it is less prone to these problems than some of its peers. Interested investors should also appreciate that one of the key attractions of the group over other large pharmaceuticals is the promising pipeline of drugs coming through research and development.
The group’s full year results for 2015 were encouraging as sales rose by 4% to £24bn despite adverse currency movements. Furthermore, sales of new products have been encouraging and are expected to hit £6bn by 2018, which is two years ahead of expectations. The hoped for future improvement should be helped by these new products, diversification (consumer healthcare, biotechnology) and increasing exposure to emerging markets.
This business is very cash generative and is committed to using this towards increasing dividends, share buybacks and bolt-on acquisitions. Moreover, the prospects from the group’s R&D are promising and should be a material driver of organic growth and give us confidence for the medium to longer term. As a result, we recommend GlaxoSmithKline as a ‘buy’ for income seekers willing to accept a lower level of risk.
There are 0 Comment(s)
Everything you wanted to know about ISAs…but were afraid to ask
The new tax year is less than a fortnight away and for ISA savers or investors, it’s hugely important. If yo...
Your right to a refund if travel is affected by train strikes
There have been a wave of train strikes in the past six months, and for anyone travelling today Friday 3 Febru...
Could you save money with a social broadband tariff?
Two-thirds of low-income households are unaware they could be saving on broadband, according to Uswitch.
What will happen if rates change
How your finances will be impacted by a rise in interest rates.
Regular Savings Calculator
Small regular contributions can build up nicely over time.
Online Savings Calculator
Work out how your online savings can build over time.
DIY investors: 10 common mistakes to avoid
For those without the help and experience of an adviser, here are 10 common DIY investor mistakes to avoid.
Mortgage down-valuations: Tips to avoid pulling out of a house sale
Down-valuations are on the rise. So, what does it mean for home buyers, and what can you do?
Five tips for surviving a bear market mauling
The S&P 500 has slipped into bear market territory and for UK investors, the FTSE 250 is also on the edge. Her...
Money Tips of the Week
© AE3 Media Ltd, Floor 7, Lincoln House, 296 - 300 High Holborn, London WC1V 7JH, Company.